Search

Issue
Title
Authors
Chronic kidney disease risk calculator: new possibilities for predicting pathology in patients with diabetes mellitus
Vikulova O.K., Elfimova A.R., Zheleznyakova A.V., Isakov M.A., Shamkhalova M.S., Shestakova M.V., Mokrysheva N.G.
The relevance of screening for cognitive and psychoemotional disorders in patients with metabolic syndrome and insulin resistance: A review
Shishkova V.N., Adasheva T.V.
Retrospective analysis of patients with diabetes mellitus type 2 and acute myocardial infarction
Bardymova T.P., Tsyretorova S.S., Donirova O.S.
The role Time in range depending on the method of assessing glycemic control in diabetes: A review
Suplotova L.A., Sudnitsyna A.S., Dushina T.S.
Association of anthropometric parameters with the risk of developing type 2 diabetes in overweight or obese individuals: cohort prospective study
Valeeva F.V., Khasanova K.B., Yilmaz T.S., Mansurova R.G.
Ipidacrine efficacy in diabetic polyneuropathy complex treatment: A review
Zinovyeva O.E., Egorov P.D., Penkina A.I., Guseinov S.S.
The role of the rs1801282 PPARG polymorphic marker in the prediction and choice of carbohydrate metabolism disorders management: A review
Khasanova K.B., Medvedeva M.S., Valeeva E.V., Rodygina Z.A., Kiseleva T.A., Valeeva F.V.
Different approaches to change gut microbiota and its influence on metabolic disorders
Shestakova E.A., Pokrovskaya E.V., Samsonova M.D.
Rossiyskiy natsional'nyy konsensus «Gestatsionnyy sakharnyy diabet: diagnostika, lechenie, poslerodovoe nablyudenie»
Dedov I.I., Krasnopol'skiy V.I., Sukhikh G.T.
Self-monitoring blood glucose levels and glycemic control in diabetes mellitus: medical and psychological aspects
Runova G.E.
Diabetes mellitus and cardiovascular diseases. An updated approach to lifestyle modification and treatment of patients with diabetes mellitus type 2
Volkova E.A., Malygina O.F.
Endocrinological aspects of bariatric surgery
Troshina E.A., Ershova E.V., Mazurina N.V.
Evaluation of calcium level in patients with diabetes mellitus according to the examination in the mobile medical center (Diamodule)
Zheleznyakova A.V., Volodicheva V.L., Vikulova O.K., Serkov A.A., Eremkina A.K., Shestakova M.V., Mokrysheva N.G.
The importance of glycemic control in patients with early forms of carbohydrate metabolism disorders in order to prevent type 2 diabetes mellitus and cardiovascular pathology
Kochergina I.I.
Innovative antidiabetic drugs as the present and future of diabetes
Insulin pump Accu-Chek Spirit Combo use in patients with type 1 diabetes mellitus therapy
Demidov N.A., Koteshkova O.M., Pashkova E.Y., Mishra O.A.
Statins and diabetes mellitus: cardiologist’s point of view
Ostroumova O.D.
Non-alcoholic fatty liver disease and diabetes mellitus: targets of metabolic tandem
Zvenigorodskaya L.A., Shinkin M.V.
Basic principles of therapeutic education of diabetic patients (clinical lecture)
Redkin Y.A.
The efficacy of αa-lipoic acid in diabetic polyneuropathy
Khramilin V.N., Andreeva V.A.
Glycemic control in patients with type 2 diabetes mellitus
Ametov A.S., Chernikova N.A.
B-complex vitamins for complex treatment of diabetic neuropathy
Biryukova E.V., Yagubova T.R.
Online monitoring of glycemia - trendy application or a real step towards compensation of diabetes?
Arbatskaya N.Y., Rybkina I.G.
Mesto pregabalina v lechenii bolevykh form diabeticheskoy polineyropatii
Bregovskiy V.B.
Insulinoterapiya sakharnogo diabeta tipa 2: chto my znaem o ee nachale?
Biryukova E.V.
Insulinoterapiya pri sakharnom diabete tipa 2: kogda, kak i chem nachinat'?
Nedosugova L.V.
Sakharnyy diabet i patologiya pochek: preimushchestva terapii, osnovannoy na inkretinakh
Shestakova M.V., Shamkhalova M.S.
Problema kognitivnogo defitsita u patsientov s metabolicheskim sindromom
Shishkova V.N., Osychenko M.E.
Angioprotektsiya nezavisima ot sakharosnizhayushchego effekta. Vozmozhno li eto?
Mkrtumyan A.M.
Koronarnaya angioplastika u bol'nykh sakharnym diabetom
Kozlov S.G., Petrova K.N.
Mimetik inkretinov eksenatid - novyy preparat dlya lecheniya sakharnogo diabeta tipa 2
Vikulova O.K., Shestakova M.V.
Blokada renin-angiotenzinovoy sistemy v profilaktike sakharnogo diabeta tipa 2
Shestakova M.V.
Arterial'naya gipertenziya i ozhirenie: printsipy ratsional'noy terapii
Belousov Y.B., Gurevich K.G.
Lechenie dislipidemii u bol'nykh sakharnym diabetom tipa 2
Kozlov S.G.
Additional possibilities of bioregulation products in correction of ENT-associated halitosis (bad smelling breath)
Karpishchenko S.A., Dzhagatspanyan I.E., Lavrenova G.V., Muratova E.I., Malay O.P., Mitrofanova I.V.
Patient management with diabetes mellitus in outpatient practice: prevention and treatment of vascular and neurological complications
Morozova T.E., Konyshko N.A.
Pioglitazone is a forgotten hypoglycemic drug with proven cardioprotective and nephroprotective properties
Pesheva E.D., Fadeev V.V.
Dynamic monitoring of cardiovascular diseases in patients with diabetes mellitus according to mobile medical center (Diamodule) in the regions of Russia
Zheleznyakova A.V., Vikulova O.K., Serkov A.A., Alferova P.A., Shestakova M.V., Dedov I.I.
What is the danger of the COVID-19 epidemic for patients with diabetes?
Glycemia self-control is necessary for successful diabetes treatment
Biriukova E.V., Askerkhanov R.G.
Antiplatelet therapy use in diabetes mellitus patients: modern approaches and ischemic heart disease prevention perspectives
Novikov V.I., Novikov K.Y.
Pathogenetic substantiation inclusion of taurine in the treatment of patients with diabetes mellitus type 2
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Gorbacheva E.E.
Diabetes mellitus after liver transplantation: pathogenesis, risk factors, verification, impact on prognosis
Kosmacheva E.D., Babich A.E.
Liver damage in patients with ischemic chronic heart and type 2 diabetes - a treacherous tandem: possible additional organoprotective therapy
Statsenko M.E., Turkina S.V., Shilina N.N.
Dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes mellitus
Morgunova T.B., Fadeev V.V.
The prospects of using the pharmacological effects of taurine in the treatment of patients with diabetes mellitus type 2
Shih E.V., Gorodetskaya G.I.
Lifestyle modification, training and self-control as important components of diabetes treatment and improvement of patients life quality
Volkova E.A., Vorokhobina N.V., Malygina O.F.
Metformin: dostizheniya i perspektivy
Nikonova T.V.
Patogeneticheskie osobennosti razvitiya arterial'noy gipertenzii v menopauze u zhenshchin i vozmozhnosti ee korrektsii
Dorofeeva G.B., Dorofeev I.V., Trofimova Y.V.
Sovremennye endovaskulyarnye tekhnologii pri lechenii neyroishemicheskoy formy sindroma diabeticheskoy stopy
Terekhin S.A., Kalashnikov V.Y.
Ispol'zovanie Aktovegina v medikamentoznoy terapii oslozhnennykh form sindroma diabeticheskoy stopy
Briskin B.S., Proshin A.V., Yakobishvili Y.I., Kuznetsov E.V.
Est' li naibolee effektivnyy algoritm lecheniya sakharnogo diabeta 2-go tipa peroral'nymi sakharosnizhayushchimi preparatami
Shestakova M.V.
Atorvastatin v lechenii bol'nykh sakharnym diabetom 2-go tipa (k 30-letiyu otkrytiya statinov)
Galyavich A.S.
Gipogonadizm u muzhchin, bol'nykh sakharnym diabetom tipa 2: epidemiologiya, klinika, diagnostika, vozmozhnosti medikamentoznoy terapii
Dedov I.I., Kalinchenko S.Y., Esaulenko D.I., Rozhivanov R.V.
Rol' kombinirovannoy terapii v lechenii sakharnogo diabeta tipa 2
Smirnova O.M.
Ot epidemii ozhireniya k epidemii sakharnogo diabeta
Butrova S.A.
Polyglandular autoimmune syndrome in adults: molecular genetic and clinical characteristics (lecture)
Troshina E.A., Larina A.A., Terekhova M.A.
Dipeptidyl peptidase-4 inhibitors use in clinical practice
Morgunova T.B., Fadeyev V.V.
Reducing the risk of chronic heart failure development in patients with arterial hypertension from the position of evidence medicine (focus on candesartan)
Evdokimova A.G., Stryuk R.I., Evdokimov V.V., Golikova A.A.
Management of patients with chronic heart failure and diabetes mellitus from the standpoint of modern recommendations and in real clinical practice
Reznik E.V., Lazarev V.A., Kalova M.R., Nikitin I.G.
THE PLACE OF VITAMIN D SUPPLEMENTATION IN THE COMPLEX THERAPY OF TYPE 2 DIABETIC PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHY
Stepanova A.P., Karonova T.L.
Antihypertensive therapy in patients with diabetes mellitus and chronic kidney disease specifications: the perspective of modern European guidelines 2018
Ostroumova O.D., Goloborodova I.V.
Dyslipidemia and atherosclerosis in type 2 diabetes mellitus patients. Statin therapy characteristics and comparative analysis: endocrinologist’s point of view
Demidova T.Y., Susareva O.V.
Motivation for improving glycemia self-monitoring efficiency in patients with diabetes mellitus: problems and solutions
Marchenkova L.A., Makarova E.V.
Autonomic heart neuropathy and its correction in type 2 diabetic patients
Krutikov E.S., Tsvetkov V.A., Chistyakova S.I.
The relationship between metabolic disorders and insulin resistance in patients with diabetes mellitus
Dorofeeva G.B., Dorofeev I.V.
Rol' protsessa obucheniya bol'nykh sakharnym diabetom tipa 2 printsipam samokontrolya i profilaktiki patologii nizhnikh konechnostey
Zhukova L.A., Gulamov A.A., Kuznetsov E.V.
Nefroprotektivnye svoystva antagonistov kal'tsiya: rol' lerkanidipina
Rudenko T.E., Kutyrina I.M.
Kontrol' glikemii - zalog uspeshnoy profilaktiki oslozhneniy pri sakharnom diabete
Garbuzova M.A.
Metformin – ot terapii metabolicheskogo sindroma k profilaktike sakharnogo diabeta tipa 2 i serdechno-sosudistykh zabolevaniy
Biryukova E.V.
Sensomotornaya i avtonomnaya formy diabeticheskoy neyropatii
Metformin: bezopasno li primenenie pri khronicheskoy bolezni pochek?
Villeval'de S.V.
«Rekomendatsii po sakharnomu diabetu, prediabetu i serdechno-sosudistym zabolevaniyam»: kommentarii
Aleksandrov A.A.
Sovremennye podkhody k kombinirovannomu lecheniyu sakharnogo diabeta 2-go tipa
Ametov A.S., Soluyanova T.N.
Anemiya pri diabeticheskoy nefropatii: prognosticheskoe znachenie, diagnostika i lechenie
Shestakova M.V., Martynov S.A.
Kombinirovannaya terapiya pri sakharnom diabete tipa 2
Ametov A.S., Mel'nik A.V., Demidova T.Y.
Sovremennye printsipy korrektsii metabolicheskogo sindroma u zhenshchin v period postmenopauzy
Grigoryan O.R.
Infektsii myagkikh tkaney u bol'nykh sakharnym diabetom
Beloborodov V.B.
Cardiovascular disorders, quality of life, and compliance in the structure of neural network prognostic model of complications development in liver transplant recipients
Kosmacheva E.D., Babich A.E., Khalafian A.A., Akin'shina V.A.
Nephroprotective properties of glucose-lowering drugs
Pokrovskaya E.V., Trubitsyna N.P., Zaytseva N.V.
Bariatricheskiy patsient: osnovnye aspekty podgotovki k khirurgicheskomu lecheniyu ozhireniya i vedeniya posle nego. Lektsiya dlya prakticheskikh vrachey
Ershova E.V., Komshilova K.A., Mazurina N.V., Troshina E.A.
CURRENT POSSIBILITIES OF GLYCEMIC SELF-CONTROL IN THE TREATMENT OF DIABETES MELLITUS. LECTURE
Biryukova E.V.
FEATURES OF DIABETIC POLYNEUROPATHY IN PATIENTS WITH DIABETES MELLITUS ACCORDING TO THE RESULTS OF ELECTRONEUROMYOGRAPHY
Batrac G.A., Metelkina N.F., Brodovskaya A.N., Andrianova E.A.
Glycemic control importance in patients with comorbid pathology
Vasiltseva O.Y., Vorozhczova I.N.
Current aspects of glycemic control in young children with diabetes mellitus
Vitebskaya A.V.
Pathogenetic background of dipeptidyl peptidase-4 inhibitors application in the management of diabetes mellitus type 2
Demidova T.Y., Kulenok S.G., Gasanzade P.A.
Comorbidity and polypharmacy: focus on cytoprotection
Shishkova V.N.
Cognitive impairments in some deficit and dismetabolic states
Pizova N.V.
Prevention of stroke and dementia in high-risk patients
Ostroumova O.D.
The characteristics of the development of acute and chronic inflammation of the upper respiratory tract in patients with diabetes mellitus
Shishkova V.N.
Nekotorye problemy profilaktiki i lecheniya sakharnogo diabeta tipa 2
Volkova E.A., Malygina O.F.
Diabeticheskaya neyropatiya: ot patogeneza k terapii
Ryabokon' I.V., Akarachkova E.S., Vershinina S.V., Kotova O.V.
Otsenka glikemii pri sakharnom diabete: samokontrol' glyukozy v krovi i izmerenie gemoglobina A1c
Ametov A.S., Stel'makh M.V.
Opyt dlitel'nogo primeneniya pervogo analoga chelovecheskogo GPP-1 liraglutida (Viktoza®) u bol'nykh sakharnym diabetom tipa 2 v real'noy klinicheskoy praktike na Dal'nem Vostoke
Morozova A.M., Borushnova O.V., Makhno E.A., Tsygankova O.G., Bocherikova E.V., Zelenya E.V.
15 let Ursosan v Rossii Metabolicheskiy sindrom, nealkogol'naya zhirovaya bolezn' pecheni i statiny: komu, kogda i kak?
Drapkina O.M., Kostyukevich M.V.
Pleyotropnye effekty superselektivnogo β1-blokatora nebivolola pri lechenii arterial'noy gipertonii i ee oslozhneniy
Bubnova M.G.
Kak nachat' insulinoterapiyu pri sakharnom diabete 2-go tipa: preimushchestva dvukhfaznykh insulinov
Shestakova M.V.
Telmisartan – novyy nefroprotektor pri sakharnom diabete: rezul'taty mezhdunarodnykh i rossiyskogo issledovaniy
Shestakova M.V., Chugunova L.A., Shamkhalova M.S.
PROBLEMA EREKTIL'NOY DISFUNKTsII. Rasprostranennost' erektil'noy disfunktsii i ee svyaz' s serdechno-sosudistoy patologiey u bol'nykh sakharnym diabetom
Vertkin A.L., Demidov N.A., Polupanova Y.S., Mikoberidze E.N., Ibragimova L.M., Khaybulina E.T., Krivtsova S.V., Kozhushkov A.I., Kondrashkina O.V., Ermachek E.A.
BETA-BLOKATORY PRI METABOLIChESKOM SINDROME I SAKhARNOM DIABETE: SOOTNOShENIE POL'ZA/RISK
Shestakova M.V.
1 - 100 of 195 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies